M3-Brigade Acquisition III Corp.: Nasdaq/NYSE listing notice — NYSE sends non-compliance notice to M3-Brigade Acquisition III for late 10-Q filing

M3-Brigade Acquisition III Corp.

Received NYSE notice on May 23, 2023 for failure to timely file Form 10-Q for quarter ended March 31, 2023.
No immediate impact on stock listing; company has until November 22, 2023 to file and regain compliance.
If not filed by deadline, NYSE may grant up to six additional months extension at its discretion.
Company cites ongoing review of relevant information as reason for delay; working to file as soon as practicable.
Potential delisting if compliance not regained within applicable cure periods.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

M3-Brigade Acquisition III Corp. received a nyse noncompliance notice notice regarding late filing (rules 802.01E).

Exchange: nyse
Notice: noncompliance notice
Deficiency: late filing
Rules: 802.01E

Exact text from the filing

May 23, 2023, the Company received a notice (the “Notice”) from the NYSE Regulation staff of the New York Stock Exchange (the “NYSE”) stating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual (the “Rule”) because it has not timely filed the Form 10-Q with the SEC. The Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Notice has no immediate effect on the listing or trading of the Company’s securities. However, if the Company fails to timely regain compliance with the Rule, the Company’s securities

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-23-045020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.